ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $1.08 billion. The enterprise value is $805.58 million.

Market Cap	1.08B
Enterprise Value	805.58M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

ORIC has 97.12 million shares outstanding. The number of shares has increased by 14.90% in one year.

Current Share Class	97.12M
Shares Outstanding	97.12M
Shares Change (YoY)	+14.90%
Shares Change (QoQ)	+9.97%
Owned by Insiders (%)	1.30%
Owned by Institutions (%)	68.07%
Float	63.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.96
P/TBV Ratio	3.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.13, with a Debt / Equity ratio of 0.02.

Current Ratio	16.13
Quick Ratio	15.65
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.82% and return on invested capital (ROIC) is -29.04%.

Return on Equity (ROE)	-43.82%
Return on Assets (ROA)	-27.69%
Return on Invested Capital (ROIC)	-29.04%
Return on Capital Employed (ROCE)	-45.52%
Revenue Per Employee	n/a
Profits Per Employee	-$1.19M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.20% in the last 52 weeks. The beta is 1.63, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	+11.20%
50-Day Moving Average	10.39
200-Day Moving Average	8.62
Relative Strength Index (RSI)	58.39
Average Volume (20 Days)	1,349,388

Short Selling Information

The latest short interest is 9.53 million, so 9.81% of the outstanding shares have been sold short.

Short Interest	9.53M
Short Previous Month	8.17M
Short % of Shares Out	9.81%
Short % of Float	15.02%
Short Ratio (days to cover)	10.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-149.67M
Pretax Income	-137.25M
Net Income	-137.25M
EBITDA	-148.48M
EBIT	-149.67M
Earnings Per Share (EPS)	-$1.89

Full Income Statement

Balance Sheet

The company has $282.51 million in cash and $8.09 million in debt, giving a net cash position of $274.43 million or $2.83 per share.

Cash & Cash Equivalents	282.51M
Total Debt	8.09M
Net Cash	274.43M
Net Cash Per Share	$2.83
Equity (Book Value)	324.00M
Book Value Per Share	3.76
Working Capital	273.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$120.23 million and capital expenditures -$1.09 million, giving a free cash flow of -$121.31 million.

Operating Cash Flow	-120.23M
Capital Expenditures	-1.09M
Free Cash Flow	-121.31M
FCF Per Share	-$1.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.90%
Shareholder Yield	-14.90%
Earnings Yield	-12.71%
FCF Yield	-11.23%

Analyst Forecast

The average price target for ORIC is $16.57, which is 49.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.57
Price Target Difference	49.01%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-11.88%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2